se of tranexamic acid in hip replacement operation to reduce bleeding
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/10/058278
- Lead Sponsor
- peoples college of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
all unilateral total hip arthroplasty cases
Exclusion Criteria
history of coagulation or bleeding disorder
history of dvt or pulmonary embolism
hepatic or renal disease
cardiovascular disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prevent blood lossTimepoint: 48 hours
- Secondary Outcome Measures
Name Time Method blood pressureTimepoint: 48 hours